Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune aspects of vitiligo.

E H Kemp1, E A Waterman, A P Weetman

  • 1Division of Clinical Sciences, Northern General Hospital, University of Sheffield, UK. e.h.kemp@sheffield.ac.uk

Autoimmunity
|October 30, 2001
PubMed
Summary

Vitiligo, a skin depigmentation disorder, is strongly linked to autoimmune processes. Evidence suggests immune cells and antibodies targeting melanocytes contribute to vitiligo development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An update on the pathogenesis of Hashimoto's thyroiditis.

Journal of endocrinological investigation·2020
Same author

Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to systemic lupus erythematosus in an Indian population.

Scandinavian journal of rheumatology·2015
Same author

Tumour necrosis factor-α antagonists as therapies for vitiligo.

The British journal of dermatology·2015
Same author

The Pathogenesis of Hashimoto's Thyroiditis: Further Developments in our Understanding.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2015
Same author

The CC genotype of the ERCC1 C118T single-nucleotide polymorphism impacts positively on the efficacy of narrowband ultraviolet B therapy for vitiligo.

The British journal of dermatology·2015

Area of Science:

  • Dermatology
  • Immunology
  • Autoimmune Disorders

Background:

  • Vitiligo is a depigmenting disorder involving melanocyte loss.
  • The precise cause of vitiligo is unknown, but an autoimmune basis is suspected.
  • Vitiligo often co-occurs with other autoimmune conditions.

Purpose of the Study:

  • To review the evidence supporting an autoimmune aetiology for vitiligo.
  • To discuss observations linking vitiligo to immune system dysregulation.

Main Methods:

  • Review of clinical observations and scientific literature.
  • Analysis of associations between vitiligo and other autoimmune diseases.
  • Examination of immunological markers in vitiligo patients.
  • Consideration of therapeutic responses and animal models.

Main Results:

  • Vitiligo frequently associates with autoimmune disorders like thyroiditis and diabetes mellitus.
  • Circulating antibodies and T lymphocytes reactive to melanocyte antigens are found in vitiligo patients.
  • Immunosuppressive therapies show effectiveness in treating vitiligo.
  • Association with Major Histocompatibility Complex (MHC) antigens supports an immune role.

Conclusions:

  • Strong evidence supports an autoimmune aetiology for vitiligo.
  • Immune mechanisms, including T-cell and antibody responses against melanocytes, are implicated in vitiligo pathogenesis.
  • Further research into the immune basis of vitiligo is warranted.

Related Experiment Videos